Hong Kong stock anomaly | GALE Pharmaceutical-B (01672.HK) rose more than 7% at the end of the day with ASC36 entering the clinical development stage. The IND application will be submitted in the second quarter of next year.

According to the Securities Times APP, GeLi Pharmaceutical-B (01672.HK) surged more than 7% in the final trading session, with a 7.05% increase, reaching 11.08 Hong Kong dollars, and a turnover of 599.31 million Hong Kong dollars.